Dementia stage mainly changes how caregivers investigate and respond to agitation—distress expressed through restlessness, upset, or aggression. Early care can rely on conversation and choice, while later care depends more on simple cues, observation, reassurance, and pain detection. The basic sequence remains the same: look for reversible causes, adjust care and surroundings, and use medication only in limited circumstances. Behavioral symptoms generally become more numerous and intense during the middle or late stages.
Medical information disclaimer: This article is for general educational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult a physician or other qualified health professional about symptoms, medications, tests, or treatment decisions.
Table of Contents
- What stays the same at every stage
- Early-stage care centers the person's voice
- Middle-stage care becomes simpler and more concrete
- Late-stage agitation may be communication without words
- Stage alone does not decide medication use
What stays the same at every stage
Do not assume that new agitation is simply dementia getting worse. A sudden escalation can signal pain, delirium, infection, constipation, thirst, fatigue, medication effects, or an environmental problem.
A practical first check is: NICE recommends assessing clinical and environmental causes before treatment and using psychosocial or environmental approaches first and throughout care. Medication is not the automatic next step simply because dementia has advanced, according to NICE dementia recommendations.
- Note when the change began and what happened immediately beforehand.
- Consider pain, illness, constipation, thirst, fatigue, and recent medication changes.
- Look for distress caused by noise, demands, routines, or the way care is being provided.
- Share a sudden or unexplained change with the health-care team.
Early-stage care centers the person's voice
In early-stage Alzheimer's, many people can still discuss what is upsetting them and participate in decisions. Ask direct but respectful questions about stressors, routines, preferred support, and what would help them remain independent. Offer workable choices instead of taking over.
For example, ask whether the person wants to complete a task now or later, or whether they prefer guidance or privacy. Record useful preferences while the person can explain them clearly. The Alzheimer's Association advises adapting communication to changing abilities; in early-stage disease, that includes speaking directly to the person and allowing time for meaningful conversation and decisions. Its communication guidance also explains how those methods should change as language abilities decline.
Middle-stage care becomes simpler and more concrete
During the middle stage, reduced language comprehension can make long explanations, repeated questions, and arguments more agitating. Move to a quiet one-to-one setting, speak slowly, ask one question at a time, and give one-step instructions. Pair words with visual cues.
Instead of explaining every part of getting dressed, hold up a shirt and calmly prompt the next action. Reassure the person rather than trying to prove that their understanding is wrong. Personal care may become another flash point because the person needs more help but still experiences the loss of control. Adapt routines, encourage whatever the person can still do, and use meaningful activities to reduce agitation and wandering.
Late-stage agitation may be communication without words
In late-stage Alzheimer's, words may give way to facial expressions, body movements, or vocal sounds. Approach from the front, identify yourself, watch the person's response, and use a calm face, tone, and gestures. Treat behavior as possible information.
Groaning, grimacing, guarding part of the body, unusual positioning, sudden upset, or aggression may indicate pain rather than a purely behavioral problem. The National Institute on Aging advises involving the health-care team when pain is suspected because a person in the final stages may not be able to describe it. Its late-stage care guidance identifies these nonverbal signs as clues caregivers should watch for.
Stage alone does not decide medication use
Guidelines reserve antipsychotic treatment for agitation causing severe distress or creating a risk of harm. The decision should reflect the behavior's severity, likely cause, and response to non-drug measures—not merely whether dementia is labeled middle or late stage. The FDA approved brexpiprazole in 2023 for agitation associated with dementia due to Alzheimer's disease.
However, pivotal trials enrolled people with Mini-Mental State Examination scores of 5–22, so they did not establish benefit for mild early disease or the most profoundly impaired late-stage patients. The FDA approval notice also notes the antipsychotic-class boxed warning about increased mortality in elderly people with dementia-related psychosis. A prescribing discussion should therefore include the specific target behavior, expected benefit, evidence limits, and warning—not dementia stage alone.
